Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.6K citations · Full text

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Yeming Wang, Dingyu Zhang, Guanhua Du et al. · The Lancet · 2020 · 3.6K citations · Full text

Treatment And Prevention, Covid-19 Pandemic, Clinical Trials +9

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

Sabué Mulangu, Lori E. Dodd, Richard T. Davey et al. · New England Journal of Medicine · 2019 · 1.6K citations · Full text

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Calvin J. Gordon, Egor P. Tchesnokov, Emma Woolner et al. · Journal of Biological Chemistry · 2020 · 1K citations · Full text

Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C

Tariq Ahmad, Philip D. Yin, Jeffrey E. Saffitz et al. · Hepatology · 2014 · 84 citations